| Authors: |
Dagenais GR; Department of Cardiology, Laval University Heart and Lung Institute, Quebec, Québec, Canada gilles.dagenais@criucpq.ulaval.ca., Dyal L; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Bosch JJ; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Leong DP; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Aboyans V; Department of Cardiology, Dupuytren University Hospital, Limoges, France.; Department of Cardiology, INSERM, U1094, Tropical Neuroepidemiology, Limoges, France., Berkowitz SD; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Massachusetts, USA., Connolly SJ; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Fox KAA; Department of Medicine, University of Edinburgh, Edinburgh, UK., Muehlhofer E; Bayer HealthCare Pharmaceuticals, Whippany, New Jersey, USA., Probstfield JL; Department of Medicine (Cardiology), University of Washington Medical Centre, Seattle, Washington, USA., Widimsky P; Cardiocenter, University Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University Prague, Prague, Czech Republic., Winkelmann BR; Kardiologische Studienpraxis und ClinPhenomics GmbH&Co, Studienzentrum Schaumainkai Frankfurt, Frankfurt, Germany., Yusuf S; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada., Eikelboom JW; Population Health Research Institute, Hamilton Health Sciences/McMaster University, Hamilton, Ontario, Canada. |